We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00218868
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : February 13, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to compare and evaluate the diagnostic performance of scrape cytology using two different cytological staining techniques, and to evaluate additional touch imprint cytology with that of histopathology of superficial basal cell carcinoma and actinic keratosis.

Condition or disease Intervention/treatment
Carcinoma, Basal Cell Porokeratosis, Disseminated Superficial Actinic Procedure: Skin scrape

Study Design

Study Type : Observational
Actual Enrollment : 66 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunvald-giemsa Stained Cutaneous Tissue Smear in Relation to Photodynamic Therapy
Study Start Date : January 2000
Primary Completion Date : February 2006
Study Completion Date : November 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
skin scrape Procedure: Skin scrape
scrape cytology using two different cytological staining techniques, and additional touch imprint cytology compared with histopathology of superficial basal cell carcinoma and actinic keratosis


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
50 BCC and 28 AK histologically verified lesions, from 41 and 25 patients, respectively
Criteria

Inclusion Criteria:

Histologically verified basal call carcinoma and actinic keratosis

Exclusion Criteria:

Morphea form of basal cell carcinoma. Pigmented form of basal cell carcinoma.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00218868


Locations
Norway
St. Olav University Hospital
Trondheim, Norway, 7006
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Eidi Christensen, MD St. Olav, University Hospital, Trondheim
More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00218868     History of Changes
Other Study ID Numbers: EC-001
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: February 13, 2012
Last Verified: February 2012

Keywords provided by Norwegian University of Science and Technology:
Cytodiagnosis
Skin Scrape
Touch Imprint
Papanicolaou
May-Grunvald-Giemsa

Additional relevant MeSH terms:
Carcinoma
Keratosis
Keratosis, Actinic
Carcinoma, Basal Cell
Porokeratosis
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Skin Diseases
Precancerous Conditions
Neoplasms, Basal Cell
Skin Diseases, Genetic
Genetic Diseases, Inborn